Skip to content
Clinical Trials – home

Rare diseases

Investigational molecules

Locations

Our offerNewsroom

Research site

Niepubliczny Zaklad Opieki Zdrowotnej Twoja Przychodnia Sp. z o.o.

Poland Ul. Krola Rogera 6, 20-857 Lublin, Poland

  • 2 trials recruiting
  • Arteriosclerosis · Heart failure with reduced ejection fraction · Cardiac failure
  • Adult patients

About Specializations

Niepubliczny Zaklad Opieki Zdrowotnej Twoja Przychodnia Sp. z o.o. in Lublin, Poland specialises in clinical trials of conditions such as Arteriosclerosis, Heart failure with reduced ejection fraction, Cardiac failure, Obesity, and other specialisations. This site conducts important research.

Main research areas of the site

Cardiovascular Diseases

The cardiology department at Niepubliczny Zaklad Opieki Zdrowotnej Twoja Przychodnia focuses on cardiovascular diseases. Researchers are studying atherosclerotic cardiovascular disease with elevated lipoprotein(a), chronic heart failure with reduced ejection fraction, and atrial fibrillation‑related stroke risk. The trials evaluate new treatments designed to lower heart‑failure hospitalizations, improve stroke prevention, and reduce major cardiac events.

  • Vericiguat in chronic heart failure with reduced ejection fraction
  • Asundexian versus apixaban for stroke prevention in atrial fibrillation
  • Olpasiran targeting lipoprotein(a) to reduce coronary events

Located in Lublin, Poland, the clinic collaborates with two investigators to advance cardiovascular care.

Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Site location
Ul. Krola Rogera 620-857 LublinPoland
Open in maps ↗
Recruiting now
2 trials
Conditions studied
11

More sites in LublinPoland

Recruiting now

Ongoing trials

Clinical trials currently enrolling participants at this site.

Condition
Type of trial
Recruitment status
Quick filters

9 clinical trials

Study on Baxdrostat and Dapagliflozin for Preventing Heart Failure in Patients at High Risk

Recruiting
Registered drug
Countries:PolandPoland
  • Participants:18–64 years · 65+ years
  • Substances:Baxdrostat
  • Sponsor:AstraZeneca AB

Cardiac failure

Recruiting
Registered drug
Countries:PolandPoland
  • Participants:18–64 years · 65+ years
  • Substances:Balcinrenone
  • Sponsor:AstraZeneca AB

Obesity+2

Not yet recruiting
Investigational
Countries:PolandPoland
  • Participants:18–64 years
  • Sponsor:Novo Nordisk A/S

Arteriosclerosis

Not recruiting
Investigational
Countries:PolandPoland
  • Participants:18–64 years · 65+ years
  • Sponsor:Amgen Inc.

Dyslipidaemia

Not recruiting
Registered drug
Countries:PolandPoland
  • Participants:18–64 years · 65+ years
  • Substances:Evolocumab
  • Sponsor:Amgen Inc.

Cardiac failure chronic+1

Not recruiting
InvestigationalNo placebo
Countries:PolandPoland
  • Participants:18–64 years · 65+ years
  • Substances:Vericiguat
  • Sponsor:Bayer AG

Type IIa hyperlipidaemia

Not recruiting
Investigational
Countries:PolandPoland
  • Participants:18–64 years · 65+ years
  • Sponsor:Merck Sharp & Dohme LLC

Atrial fibrillation+2

Not recruiting
Registered drug
Countries:PolandPoland
  • Participants:18–64 years · 65+ years
  • Substances:Apixaban
  • Sponsor:Bayer AG

Heart failure with reduced ejection fraction

Not recruiting
Investigational
Countries:PolandPoland
  • Participants:18–64 years · 65+ years
  • Substances:Vericiguat
  • Sponsor:Merck Sharp & Dohme LLC
Is this your site?

Join our network of research sites

Get verified: confirm your contact details and recruitment status with us, appear first on the pages of your trials and receive patient requests directly.

See the offer for sites
Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.